CareRx Corporation Stock

Equities

CRRX

CA14173C1059

Drug Retailers

Delayed Toronto S.E. 12:44:36 2024-06-03 pm EDT 5-day change 1st Jan Change
2.26 CAD +4.63% Intraday chart for CareRx Corporation +9.71% +40.37%
Sales 2024 * 366M 268M Sales 2025 * 387M 283M Capitalization 130M 95.1M
Net income 2024 * -2M -1.46M Net income 2025 * -2M -1.46M EV / Sales 2024 * 0.35 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.34 x
P/E ratio 2024 *
52.3 x
P/E ratio 2025 *
12.9 x
Employees 1,559
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.57%
More Fundamentals * Assessed data
Dynamic Chart
CareRx Brief: Dalton will be succeeded by Jeff Watson, a current independent director of the Board MT
CareRx Brief: Kevin Dalton, Chairman of the Board for the last six years, will be retiring as Chairman effectively immediately MT
CareRx Corporation Announces Board Changes CI
CareRx Brief: Company Undertaking a search for a new CFO; Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim CFO MT
CareRx Brief: Says Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity MT
CareRx Corporation Announces CFO Transition CI
Transcript : CareRx Corporation, Q1 2024 Earnings Call, May 10, 2024
CareRx Q1 Net Loss Narrows, Revenue Dips MT
Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023. CI
CareRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
CareRx Brief: Q1 Revenue $89.7 million; Net loss for the quarter was $0.5 million MT
North American Morning Briefing : Stocks Set to -2- DJ
CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes MT
CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes MT
CareRx Brief: In connection with Prior announced normal course issuer bid to Buy Up To 1 Million of its common shares, it has entered into an automatic share purchase plan MT
More news
1 day-0.92%
1 week+4.85%
1 month-8.09%
3 months+35.00%
6 months+60.00%
Current year+34.16%
More quotes
1 week
2.04
Extreme 2.04
2.22
1 month
2.00
Extreme 2
2.35
Current year
1.45
Extreme 1.45
2.42
1 year
1.10
Extreme 1.1
2.43
3 years
1.10
Extreme 1.1
6.94
5 years
1.10
Extreme 1.1
6.94
10 years
1.10
Extreme 1.1
18.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-10-31
Director of Finance/CFO - 16-12-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 56 17-03-29
Director/Board Member - 20-05-06
Director/Board Member - 21-05-31
More insiders
Date Price Change Volume
24-06-03 2.26 +4.63% 28 279
24-05-31 2.16 -0.92% 18,000
24-05-30 2.18 +4.31% 23,724
24-05-29 2.09 +0.97% 8,800
24-05-28 2.07 +0.49% 3,300

Delayed Quote Toronto S.E., May 31, 2024 at 04:00 pm EDT

More quotes
CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.16 CAD
Average target price
3.781 CAD
Spread / Average Target
+75.06%
Consensus